Laboratory for Translational Research in Imaging Pharmaceuticals, The Wright Center of Innovation in Biomedical Imaging, Department of Radiology, The Ohio State University, Columbus, Ohio, USA.
Cancer Biother Radiopharm. 2022 Apr;37(3):173-185. doi: 10.1089/cbr.2021.0233. Epub 2021 Nov 12.
Several radioisotopes of iodine (I, I, I, and I) are available for medical use. One of them can be used, depending on the application, for radioiodine labeling of New Chemical Entities (NCEs) and biomolecules (peptides, proteins, protein fragments, monoclonal antibodies, etc.) for the development of novel imaging and therapeutic pharmaceuticals. Direct, using inorganic and organic oxidizing agents and enzyme catalysts, and indirect, using prosthetic groups, radioiodine-labeling methods have been used routinely in the past. In this report, a comprehensive review of the physical properties of various iodine radionuclides, their medical applications, and a summary of various radioiodine labeling reagents and methods for NCEs and biomolecules are provided.
几种碘的放射性同位素(I、I、I 和 I)可用于医学用途。其中一种可根据应用情况,用于放射性碘标记新化学实体(NCE)和生物分子(肽、蛋白质、蛋白质片段、单克隆抗体等),以开发新型成像和治疗药物。过去,曾常规使用直接法(使用无机和有机氧化剂和酶催化剂)和间接法(使用辅基)进行放射性碘标记。本报告全面综述了各种碘放射性核素的物理性质、它们的医学应用以及用于 NCE 和生物分子的各种放射性碘标记试剂和方法的总结。